Parkinson’s disease mouse models in translational research

被引:0
|
作者
Paul M. A. Antony
Nico J. Diederich
Rudi Balling
机构
[1] University of Luxembourg,Luxembourg Centre for Systems Biomedicine (LCSB)
[2] Centre Hospitalier de Luxembourg,Department of Neuroscience
来源
Mammalian Genome | 2011年 / 22卷
关键词
Bacterial Artificial Chromosome; MPTP; Translational Research; Nigrostriatal Dopaminergic Neuron; Nonmotor Symptom;
D O I
暂无
中图分类号
学科分类号
摘要
Animal models with high predictive power are a prerequisite for translational research. The closer the similarity of a model to Parkinson’s disease (PD), the higher is the predictive value for clinical trials. An ideal PD model should present behavioral signs and pathology that resemble the human disease. The increasing understanding of PD stratification and etiology, however, complicates the choice of adequate animal models for preclinical studies. An ultimate mouse model, relevant to address all PD-related questions, is yet to be developed. However, many of the existing models are useful in answering specific questions. An appropriate model should be chosen after considering both the context of the research and the model properties. This review addresses the validity, strengths, and limitations of current PD mouse models for translational research.
引用
收藏
页码:401 / 419
页数:18
相关论文
共 50 条
  • [21] Gait dynamics in mouse models of Parkinson's disease and Huntington's disease
    Amende I.
    Kale A.
    McCue S.
    Glazier S.
    Morgan J.P.
    Hampton T.G.
    Journal of NeuroEngineering and Rehabilitation, 2 (1)
  • [22] RECENT ADVANCES IN PARKINSON'S DISEASE: TRANSLATIONAL AND CLINICAL RESEARCH Preface
    Bjorklund, Anders
    Cenci, M. Angela
    RECENT ADVANCES IN PARKINSONS DISEASE: TRANSLATIONAL AND CLINICAL RESEARCH, 2010, 184 : VII - VIII
  • [23] Limitations of cellular models in Parkinson's disease research
    Falkenburger, B. H.
    Schulz, J. B.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2006, (70): : 261 - 268
  • [24] The search for genetic mouse models of prodromal Parkinson's disease
    Smith, Gaynor A.
    Isacson, Ole
    Dunnett, Stephen B.
    EXPERIMENTAL NEUROLOGY, 2012, 237 (02) : 267 - 273
  • [25] 'Rejuvenation' protects neurons in mouse models of Parkinson's disease
    Chan, C. Savio
    Guzman, Jaime N.
    Ilijic, Ema
    Mercer, Jeff N.
    Rick, Caroline
    Tkatch, Tatiana
    Meredith, Gloria E.
    Surmeier, D. James
    NATURE, 2007, 447 (7148) : 1081 - U5
  • [26] Neuroprotective effects of fingolimod in mouse models of Parkinson's disease
    Zhao, Peng
    Yang, Xiaoxia
    Yang, Liu
    Li, Minshu
    Wood, Kristofer
    Liu, Qiang
    Zhu, Xiaodong
    FASEB JOURNAL, 2017, 31 (01): : 172 - 179
  • [27] Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
    Fleming, Sheila M.
    Ekhator, Osunde R.
    Ghisays, Valentins
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (76):
  • [28] The role of lipid metabolism in mouse models of Parkinson's disease
    Trabjerg, M.
    Andersen, D.
    Huntjens, P.
    Mork, K.
    Skjonnemand, M.
    Oklinski, M.
    Morkholt, A.
    Huijbers, I.
    Pritchard, C.
    Kroese, L.
    Nieland, J.
    MOVEMENT DISORDERS, 2019, 34 : S734 - S734
  • [29] Genetic mouse models of Parkinson's disease: The state of the art
    Magen, Iddo
    Chesselet, Marie-Francoise
    RECENT ADVANCES IN PARKINSONS DISEASE: TRANSLATIONAL AND CLINICAL RESEARCH, 2010, 184 : 53 - 87
  • [30] Oxidative Stress in Genetic Mouse Models of Parkinson's Disease
    Varcin, Mustafa
    Bentea, Eduard
    Michotte, Yvette
    Sarre, Sophie
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2012, 2012